The annualised 3-year survival rates of the entire cohort ranged between 65.0% (95% CI 58.8–71.8%) and 75.3% (95% CI 69.9–81.2%); here, a slight trend towards improvement cannot be excluded ( figure 4a ).
← all excerpts
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry.
1
—
—